組換えC因子(rFC)アッセイの世界市場2019-2027

◆英語タイトル:Recombinant Factor C Assay - Global Market Outlook (2019-2027)
◆商品コード:SMRC20JL384
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2020年6月30日
◆ページ数:171
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥435,750見積依頼/購入/質問フォーム
Five UserUSD5,250 ⇒換算¥551,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥787,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、組換えC因子(rFC)アッセイの世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、エンドユーザー別(受託研究機関(CRO)、バイオテクノロジー企業、医療機器会社、製薬会社)分析、ブランド別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・組換えC因子(rFC)アッセイの世界市場規模:エンドユーザー別(受託研究機関(CRO)、バイオテクノロジー企業、医療機器会社、製薬会社)
・組換えC因子(rFC)アッセイの世界市場規模:ブランド別
・組換えC因子(rFC)アッセイの世界市場規模:地域別
・主要な市場開拓
・企業情報
【レポートの概要】

According to Stratistics MRC, the Global Recombinant Factor C Assay Market is accounted for $14.29 million in 2019 and is expected to reach $30.40 million by 2027 growing at a CAGR of 9.9% during the forecast period. The rise in need of alternative endotoxin detection tests and cost advantages by helping in reducing the operator risks is propelling the market growth. However, the lack of long-term studies that validate rFC for combination testing of unknown samples is hampering the market growth.

Recombinant factor C (rFC) assay is an alternative to LAL tests utilized for endotoxin testing of the products for pyrogens. Recombinant factor C (rFC) assay is a synthetic correspondent of Factor C and is the first part of the horseshoe crab clotting cascade, which is activated in response to endotoxins.

Based on the brand, the PyroGene segment is going to have a lucrative growth during the forecast period as it is being the first marketed rFC assay product used as an alternative to LAL tests and also it is one of the main products tested as an alternative to LAL tests to conserve the Limulus species. By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to incorporation of rFC as a recognized endotoxin detection test by pharmacopoeias, and focus on conservation of the Limulus species.

Some of the key players profiled in the Recombinant Factor C Assay Market include Hyglos GmbH – a bioMérieux Company and Lonza Group.

End Users Covered:
• Contract Research Organizations (CROs)
• Biotechnology Companies
• Medical Device Companies
• Pharmaceutical Companies

Brands Covered:
• EndoNext
• PyroGene

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client’s interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Recombinant Factor C Assay Market, By End User
5.1 Introduction
5.2 Contract Research Organizations (CROs)
5.3 Biotechnology Companies
5.4 Medical Device Companies
5.5 Pharmaceutical Companies

6 Global Recombinant Factor C Assay Market, By Brand
6.1 Introduction
6.2 EndoNext
6.2.1 Endozyme II GO
6.2.2 EndoLisa
6.2.3 Endozyme II
6.3 PyroGene
6.3.1 PyroGene rFC (192 tests)
6.3.2 PyroGene Bulk rFC (2,880 tests)

7 Global Recombinant Factor C Assay Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Hyglos GmbH – a bioMérieux Company
9.2 Lonza Group

List of Tables
Table 1 Global Recombinant Factor C Assay Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
Table 3 Global Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
Table 4 Global Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
Table 5 Global Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
Table 6 Global Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
Table 7 Global Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
Table 8 Global Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
Table 9 Global Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
Table 10 Global Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
Table 11 Global Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
Table 12 Global Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
Table 13 Global Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
Table 14 Global Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
Table 15 North America Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
Table 16 North America Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
Table 17 North America Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
Table 18 North America Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
Table 19 North America Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
Table 20 North America Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
Table 21 North America Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
Table 22 North America Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
Table 23 North America Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
Table 24 North America Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
Table 25 North America Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
Table 26 North America Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
Table 27 North America Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
Table 28 North America Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
Table 29 Europe Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
Table 30 Europe Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
Table 31 Europe Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
Table 32 Europe Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
Table 33 Europe Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
Table 34 Europe Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
Table 35 Europe Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
Table 36 Europe Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
Table 37 Europe Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
Table 38 Europe Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
Table 39 Europe Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
Table 40 Europe Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
Table 41 Europe Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
Table 42 Europe Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
Table 43 Asia Pacific Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
Table 44 Asia Pacific Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
Table 45 Asia Pacific Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
Table 46 Asia Pacific Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
Table 47 Asia Pacific Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
Table 48 Asia Pacific Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
Table 49 Asia Pacific Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
Table 50 Asia Pacific Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
Table 51 Asia Pacific Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
Table 52 Asia Pacific Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
Table 53 Asia Pacific Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
Table 54 Asia Pacific Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
Table 55 Asia Pacific Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
Table 56 Asia Pacific Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
Table 57 South America Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
Table 58 South America Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
Table 59 South America Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
Table 60 South America Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
Table 61 South America Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
Table 62 South America Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
Table 63 South America Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
Table 64 South America Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
Table 65 South America Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
Table 66 South America Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
Table 67 South America Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
Table 68 South America Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
Table 69 South America Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
Table 70 South America Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
Table 71 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
Table 72 Middle East & Africa Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
Table 73 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
Table 74 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
Table 75 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
Table 76 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
Table 77 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
Table 78 Middle East & Africa Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
Table 79 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
Table 80 Middle East & Africa Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
Table 81 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
Table 82 Middle East & Africa Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
Table 83 Middle East & Africa Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
Table 84 Middle East & Africa Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[組換えC因子(rFC)アッセイの世界市場2019-2027]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆